OUVRY; Gilles

Patent Applications and Registrations

Patent applications and USPTO patent grants for OUVRY; Gilles.The latest application filed is for "trpa1 antagonists for use in the treatment of atopic dermatitis".

Company Profile

12.9.14

OUVRY; Gilles - Biot FR
Ouvry; Gilles - Macclesfield GB
Ouvry; Gilles - Cheshire GB
Ouvry; Gilles - Reims FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Trpa1 Antagonists For Use In The Treatment Of Atopic Dermatitis App 20200390774 - OUVRY; Gilles ; et al.	2020-12-17
Novel Mtor Inhibitor Compounds App 20200317679 - CLARY; Laurence ; et al.	2020-10-08
Mtor Inhibitor Compounds App 20200317683 - CLARY; Laurence ; et al.	2020-10-08
Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T)) Grant 10,752,617 - Musicki , et al. A	2020-08-25
Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T)) Grant 10,618,890 - Musicki , et al.	2020-04-14
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine and cosmetics Grant 10,556,883 - Ouvry , et al. Feb	2020-02-11
Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t)) Grant 10,550,110 - Musicki , et al. Fe	2020-02-04
Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR.gamma.(T)) Grant 10,457,637 - Musicki , et al. Oc	2019-10-29
Trpa1 Antagonists For Use In The Treatment Of Atopic Dermatitis App 20190307758 - OUVRY; Gilles ; et al.	2019-10-10
Indazole Sulfonamide Derivatives As Inverse Agonists Of Retinoid-related Orphan Receptor Gamma (ror Gamma (t)) App 20190202819 - MUSICKI; Branislav ; et al.	2019-07-04
Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR .gamma. (T)) Grant 10,246,440 - Musicki , et al.	2019-04-02
Benzimidazole Sulfonamide Derivatives As Inverse Agonists Of Retinoid-related Orphan Receptor Gamma (ror Gamma (t)) App 20190071433 - MUSICKI; Branislav ; et al.	2019-03-07
Tetrahydroquinoline Sulfonamide Derivatives As Inverse Agonists Of Retinoid-related Orphan Receptor Gamma (ror Gamma (t)) App 20180265500 - MUSICKI; Branislav ; et al.	2018-09-20
Benzenesulfonamide Derivatives As Inverse Agonists Of Retinoid-related Orphan Receptor Gamma (ror Gamma (t)) App 20180170869 - MUSICKI; Branislav ; et al.	2018-06-21
Indazole Sulfonamide Derivatives As Inverse Agonists Of Retinoid-related Orphan Receptor Gamma (ror Gamma (t)) App 20170342062 - MUSICKI; Branislav ; et al.	2017-11-30
Benzenesulfonamide Compounds, Method For Synthesizing Same, And Use Thereof In Medicine And Cosmetics App 20170247353 - OUVRY; Gilles ; et al.	2017-08-31
Chemical compounds Grant 9,657,008 - Barlaam , et al. May 23, 2	2017-05-23
Chemical Compounds App 20160137634 - Barlaam; Bernard Christophe ; et al.	2016-05-19
Chemical compounds Grant 9,156,831 - Barlaam , et al. October 13, 2	2015-10-13
Chemical Compounds App 20140206700 - BARLAAM; Bernard Christophe ; et al.	2014-07-24
Pyridine and pyrazine derivatives -083 Grant 8,017,611 - Barlaam , et al. September 13, 2	2011-09-13
Novel 6-azaindole Aminopyrimidine Derivatives Having Nik Inhibitory Activity App 20110183975 - Goto; Yasuhiro ; et al.	2011-07-28
Pyridine And Pyrazine Derivatives - 083 App 20090118305 - Barlaam; Bernard Christophe ; et al.	2009-05-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.